image 2 image 4
Skip Navigation Links
 Home 
 Congress Structure 
 Important Dates 
 Venue 
 Registration 
 Pre Registered 
 Hotel Info 
 Abstracts 
 Scientific Program 
 Social Program 
 Exhibition 
 Contact Us 
       XXIV Annual Congress of the Iranian Society of Ophthalmology        بـیــست و چهارمین کنــگــره سـالیـانه انـجـمـن چـشـم پـزشـکی ایـــران
مقاله Abstract


Title: Outcomes of MyoRing implantation to treat moderate and severe keratoconus: 3 months versus 1- year follow-up.
Author(s): Sahar Mojaled Nobari, Consuelo Villena(PhD),Khosrow Jadidi(MD)
Presentation Type: Poster
Subject: Cornea and Anterior Segment
Others:
Presenting Author:
Name: Sahar Mojaled Nobari
Affiliation :(optional) PhD candidate of Optometry in Complutense University , Madrid, Spain
E mail: sahar_optica@hotmail.es
Phone: 44228239
Mobile: 09124949800,09127374821
Purpose:

To report the 1- year visual and refractive outcomes after full-ring intracorneal implantation (MyoRing) to correct moderate and severe keratoconus and comparison the outcomes between 3 and 12 months after surgery.

Methods:

This retrospective study included 54 eyes of 50 patients (27 male and 23 female) with moderate and severe keratoconus. The MyoRing (Dioptex GmbH) was implanted by the creation of a pocket within the corneal stroma with the PocketMaker microkeratome. All cases completed one year follow-up. Uncorrected visual acuity (UCVA), best spectacle-corrected visual acuity (BSCVA), manifest refraction, spherical equivalent (SE), keratometry readings were clinically and statistically evaluated.

Results:

The mean UCVA (in decimal value) improved significantly from 0.06 ± 0.24 to 0.63 ± 0.09 and the mean BSCVA from 0.32 ± 0.22 to 0.8 ± 0.06 respectively (p<0.001). The spherical equivalent and the mean keratometric value decreased significantly by 6 diopters (p<0.001). There was no significant difference in visual and refractive outcomes between 3 months and 1 year postoperatively.

Conclusion:

Following MyoRing implantation in keratoconic eyes the mean SE, UCVA and BSCVA remained stable 3 months after surgery. Management of moderate and severe keratoconus using MyoRring implantation is safe and effective procedure.

Attachment: 5880.pptx





Skip Navigation Links
        صفحه اصلی
        ساختار کنگره
        تاریخ های مهم
        مکان برگزاری
        ثبت نام
        ثبت نام شدگان
        اطلاعات هتل - رزرو
        ارسال مقالات
        برنامه کنگره
        نمایشگاه
        تماس با ما
        جستجوی سخنران
        برگزیدگان جشنواره فیلم
        برگزیدگان جشنواره عکس
 
Last News

  - بـیــست و چهارمین کنــگــره سـالیـانه انـجـمـن چـشـم پـزشـکی ایـــران